Rezivertinib
Rezivertinib (BPI-7711) is an orally available, selective and potent inhibitor of tyrosine kinase (EGFR) with antitumor activity for central nervous system disorders.
Product Specifications
CAS Number
1835667-12-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
486.57
Molecular Formula
C27H30N6O3
Notes
Research use only, not for human use.
Receptor
EGFR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-08924AF350 100 µL
Rabbit Monoclonal CD45RB Antibody (PTPRC/2877R) [Alexa Fluor 350]
Ask
View Details 